Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism
Authors:
Open Access
- 25 September 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1474688
Abstract
Macrophage-myofibroblast transformation (MMT) transforms macrophages into myofibroblasts in a specific inflammation or injury microenvironment. MMT is an essential biological process in fibrosis-related diseases involving the lung, heart, kidney, liver, skeletal muscle, and other organs and tissues. This process consists of interacting with various cells and molecules and activating different signal transduction pathways. This review deeply discussed the molecular mechanism of MMT, clarified crucial signal pathways, multiple cytokines, and growth factors, and formed a complex regulatory network. Significantly, the critical role of transforming growth factor-β (TGF-β) and its downstream signaling pathways in this process were clarified. Furthermore, we discussed the significance of MMT in physiological and pathological conditions, such as pulmonary fibrosis and cardiac fibrosis. This review provides a new perspective for understanding the interaction between macrophages and myofibroblasts and new strategies and targets for the prevention and treatment of MMT in fibrotic diseases.Keywords
This publication has 308 references indexed in Scilit:
- Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage–Myofibroblast Transition in Non‐Small‐Cell Lung CarcinomaAdvanced Science, 2023
- Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast TransitionAdvanced Science, 2021
- M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndromeJournal of Cellular Physiology, 2021
- Regulatory macrophages: Setting the Threshold for TherapyEuropean Journal of Immunology, 2011
- Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?Arthritis & Rheumatism, 2011
- Elie Metchnikoff: Father of natural immunityEuropean Journal of Immunology, 2008
- Notch2 negatively regulates myofibroblastic differentiation of myoblastsJournal of Cellular Physiology, 2006
- Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosisThe Journal of Pathology, 2003
- The myofibroblast in wound healing and fibrocontractive diseasesThe Journal of Pathology, 2003
- Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 2003